CIK: 0001281446 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $153,802 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | 500,000 | $19,755 | 12.8% | $35.97 | -9.0% | COM | 462222100 |
| RZLT | REZOLUTE INC | 3,033,462 | $13,529 | 8.8% | $4.03 | -7.9% | COM NEW | 76200L309 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 2,000,000 | $12,820 | 8.3% | $3.68 | +32.1% | COM | 03237H101 |
| LEGN | LEGEND BIOTECH CORP | 350,000 | $12,422 | 8.1% | $34.87 | — | SPONSORED ADS | 52490G102 |
| ABVX | ABIVAX SA | 1,291,617 | $9,881 | 6.4% | $12.06 | — | SPONSORED ADS | 00370M103 |
| NGNE | NEUROGENE INC | 485,859 | $7,264 | 4.7% | $14.71 | +6.7% | COM | 64135M105 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,985,915 | $7,229 | 4.7% | $2.04 | +34.6% | COM | 00972D105 |
| EOLS | EVOLUS INC | 720,118 | $6,632 | 4.3% | $9.83 | +4.1% | COM | 30052C107 |
| ACLX | ARCELLX INC | 100,000 | $6,585 | 4.3% | $64.73 | -3.8% | COMMON STOCK | 03940C100 |
| XENE | XENON PHARMACEUTICALS INC | 200,000 | $6,260 | 4.1% | $41.35 | -21.1% | COM | 98420N105 |
| — | AKERO THERAPEUTICS INC | 103,848 | $5,541 | 3.6% | $53.36 | — | COM | 00973Y108 |
| JBIO | JADE BIOSCIENCES INC | 498,054 | $4,976 | 3.2% | $33.31 | 0.0% | COM NEW | 008064206 |
| CYTK | CYTOKINETICS INC | 150,000 | $4,956 | 3.2% | $51.61 | -32.6% | COM NEW | 23282W605 |
| IMVT | IMMUNOVANT INC | 262,176 | $4,195 | 2.7% | $20.92 | -27.7% | COM | 45258J102 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 796,558 | $3,800 | 2.5% | $6.18 | 0.0% | COM NEW | 90466Y202 |
| KALV | KALVISTA PHARMACEUTICALS INC | 323,170 | $3,653 | 2.4% | $11.31 | +8.1% | COM | 483497103 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,500,000 | $3,465 | 2.3% | $2.17 | 0.0% | COM SHS | 877619106 |
| DBVT | DBV TECHNOLOGIES S A | 374,679 | $3,432 | 2.2% | $9.16 | — | SPONSORED ADS | 23306J309 |
| ZURA | ZURA BIO LTD | 3,170,194 | $3,329 | 2.2% | $6.43 | -81.4% | CLASS A ORD SHS | G9TY5A101 |
| UPB | UPSTREAM BIO INC | 300,000 | $3,294 | 2.1% | $22.33 | -58.6% | COM | 91678A107 |
| CNTX | CONTEXT THERAPEUTICS INC | 4,683,711 | $3,069 | 2.0% | $1.72 | -58.3% | COM | 21077P108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 225,000 | $2,957 | 1.9% | $13.97 | — | SPONSORED ADS | 152309100 |
| SRRK | SCHOLAR ROCK HLDG CORP | 61,607 | $2,182 | 1.4% | $31.39 | 0.0% | COM | 80706P103 |
| — | PROMIS NEUROSCIENCES INC | 2,645,128 | $1,280 | 0.8% | $1.25 | — | COM NEW | 74346M406 |
| PLRX | PLIANT THERAPEUTICS INC | 850,000 | $986 | 0.6% | $16.18 | -91.3% | COM | 729139105 |
| BBOT | HELIX ACQUISITION CORP II | 29,381 | $312 | 0.2% | $10.35 | +4.5% | CL A ORD SHS | G4444H101 |